Lower Health Care Costs Act

3.0.0 5668 2023-01-11T13:44:19Z 2023-01-11T13:44:19Z House HR 2020-01-24 116 [Congressional Record Volume 166, Number 15 (Friday, January 24, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. MATSUI:H.R. 5668.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the US Constitution[Page H537]]]> sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2020-11-18T18:43:23Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Markup by 2020-03-11T18:48:18Z Referred to 2020-01-25T15:01:23Z Reported by 2020-11-16T20:35:49Z Markup by 2020-07-15T13:27:16Z Referred to 2020-01-24T19:01:50Z H. Rept. 116-573 Lower Health Care Costs Act 116 1895 S 2019-07-08 Placed on Senate Legislative Calendar under General Orders. Calendar No. 133. Related bill CRS A bill to establish a process for updating the labeling of certain drugs with outdated labeling. 116 1897 S 2019-06-19 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS Fair Care Act of 2020 116 4796 S 2020-10-05 Read twice and referred to the Committee on Finance. Related bill CRS Fair Care Act of 2020 116 8527 HR 2020-10-02 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, the Judiciary, Oversight and Reform, House Administration, Rules, the Budget, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2020-11-18 sshr00 Health, Education, Labor, and Pensions Committee Senate Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2020-11-17 12:25:13 Motion to reconsider laid on the table Agreed to without objection. Floor H38310 2 House floor actions 2020-11-17 12:25:02 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5805-5806) Floor H37300 2 House floor actions 2020-11-17 12:25:02 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5805-5806) Floor 8000 9 Library of Congress 2020-11-17 12:18:02 DEBATE - The House proceeded with forty minutes of debate on H.R. 5668. Floor H8D000 2 House floor actions 2020-11-17 12:17:58 Considered under suspension of the rules. (consideration: CR H5805-5807) Floor H30000 2 House floor actions 2020-11-17 12:17:23 Mr. Pallone moved to suspend the rules and pass the bill, as amended. Floor H30300 2 House floor actions 2020-11-16 Placed on the Union Calendar, Calendar No. 471. Calendars H12410 2 House floor actions U00471 2020-11-16 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2020-11-16 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2020-07-15 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2020-07-15 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2020-03-11 hsif14 Health Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2020-03-11 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2020-01-25 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2020-01-24 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-01-24 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-01-24 Introduced in House IntroReferral 1000 9 Library of Congress M001163 Rep. Matsui, Doris O. [D-CA-6] Doris Matsui D CA O. 6 N G000558 Rep. Guthrie, Brett [R-KY-2] Brett Guthrie R KY 2 2020-01-24 True T000479 Rep. Taylor, Van [R-TX-3] Van Taylor R TX 3 2020-11-16 False 2020-10-29T20:08:00Z H.R. 5668, Making Objective Drug Evidence Revisions for New Labeling Act of 2020 https://www.cbo.gov/publication/56712 As ordered reported by the House Committee on Energy and Commerce on July 15, 2020 Health Congressional oversight Drug safety, medical device, and laboratory regulation Prescription drugs Health

00 2020-01-24 Introduced in House 2021-09-07T14:23:22Z Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

]]>

53 2020-11-17 Passed House 2021-09-07T15:13:18Z Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

]]>

MODERN Labeling Act of 2020 Display Title MODERN Labeling Act of 2020 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to modernize the labeling of certain generic drugs, and for other purposes. Engrossed in House EH Short Title(s) as Passed House MODERN Labeling Act of 2020 H House Engrossed in House EH Short Title(s) as Passed House Making Objective Drug Evidence Revisions for New Labeling Act of 2020 H House Engrossed in House EH Short Titles as Passed House MODERN Labeling Act of 2020 H House Short Titles as Passed House Making Objective Drug Evidence Revisions for New Labeling Act of 2020 H House Short Title(s) as Introduced Making Objective Drug Evidence Revisions for New Labeling Act of 2020 Introduced in House IH Short Title(s) as Introduced MODERN Labeling Act of 2020 Introduced in House IH Short Title(s) as Reported to House Making Objective Drug Evidence Revisions for New Labeling Act of 2020 H House Reported in House RH Short Title(s) as Reported to House MODERN Labeling Act of 2020 H House Reported in House RH Referred in Senate 2020-11-18T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr5668rfs/xml/BILLS-116hr5668rfs.xml Engrossed in House 2020-11-17T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr5668eh/xml/BILLS-116hr5668eh.xml Reported in House 2020-11-16T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr5668rh/xml/BILLS-116hr5668rh.xml Introduced in House 2020-01-24T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr5668ih/xml/BILLS-116hr5668ih.xml 2020-11-18 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.